Invasive hydatidiform mole
Invasive hydatidiform mole is a rare form of gestational trophoblastic disease that invades the muscle layer of the uterus. It is a type of molar pregnancy and is characterized by the presence of hydatidiform mole tissue that grows into the muscles of the uterus.
Causes[edit | edit source]
Invasive hydatidiform mole is caused by an abnormal fertilization process. Instead of a normal pregnancy developing, a mass of abnormal tissue (a mole) grows in the uterus. This mole can invade the muscle layer of the uterus, leading to an invasive hydatidiform mole.
Symptoms[edit | edit source]
Symptoms of invasive hydatidiform mole may include vaginal bleeding, anemia, hyperemesis gravidarum (severe nausea and vomiting), and preeclampsia (high blood pressure and protein in the urine).
Diagnosis[edit | edit source]
Diagnosis of invasive hydatidiform mole is usually made through a combination of ultrasound imaging and blood tests to measure levels of human chorionic gonadotropin (hCG), a hormone produced by the placenta during pregnancy.
Treatment[edit | edit source]
Treatment for invasive hydatidiform mole typically involves surgery to remove the mole, followed by chemotherapy to kill any remaining abnormal cells.
Prognosis[edit | edit source]
With early detection and treatment, the prognosis for invasive hydatidiform mole is generally good. However, regular follow-up is necessary to monitor for potential complications, including the development of choriocarcinoma, a rare form of cancer.
See also[edit | edit source]
Invasive hydatidiform mole Resources | ||
---|---|---|
|
|
Translate to: East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.Contributors: Admin, Prab R. Tumpati, MD